Moderna
is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases... Read moreModerna
is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases... Read more
News
Partnership
Mar 05, 2025
Investing.com
Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck By Investing.com
Funding
Jan 20, 2025
The Wall Street Journal
Moderna received $590M in Unattributed Funding
Regulatory
Nov 11, 2024
Pharamceutical Technology
Moderna's mRESVIA vaccine gains Health Canada approval
Conference Presentation
Oct 31, 2024
FinanzNachrichten
Moderna, Inc.: Moderna to Present at Upcoming Conferences in November 2024
